Overview

An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis

Status:
Completed
Trial end date:
2009-04-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Tanezumab